ArticleEcancermedicalscience2026

Pathologic complete response and survival in early-stage HER2-positive breast cancer patients treated with or without anthracyclines.

Francisco Acevedo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.